NCT06282679View on ClinicalTrials.gov

Clinical Observation of Botulinum Toxin A Treatment in the Treatment of Rosacea

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

March 1, 2024

Study Completion Date

June 28, 2024

Conditions
RosaceaBotulinum Toxin
Interventions
DRUG

Botulinum Toxin Type A Injection [Botox]

you are asked to return to the hospital for follow-up at weeks 2, 4, 8, and 12

Trial Locations (1)

210006

RECRUITING

Jie Dai, Nanjing

All Listed Sponsors
lead

Nanjing First Hospital, Nanjing Medical University

OTHER